SELLAS Life Sciences Group Capital Expenditures (CapEx) Growth & History (SLS)

SELLAS Life Sciences Group's capital expenditures (capex) was $5.5M for fiscal 2023.

View full SELLAS Life Sciences Group company overview

SELLAS Life Sciences Group annual capital expenditures (capex) history

SELLAS Life Sciences Group annual capital expenditures (capex)

Fiscal yearPeriod endedCapital expenditures (CapEx)ChangeGrowth
20232023-12-31$5.5M$1.0M+22.22%
20222022-12-31$4.5M
20162016-12-31$6,000−$147,000−96.08%
20152015-12-31$153,000$96,000+168.42%
20142014-12-31$57,000−$263,000−82.19%
20132013-12-31$320,000
20112011-12-31$53,000−$53,000−50.00%
20102010-12-31$106,000

SELLAS Life Sciences Group capital expenditures (capex) trends

Between the periods ended 2010-12-31 and 2023-12-31, SELLAS Life Sciences Group's capital expenditures (capex) increased from $106,000 to $5.5M, a change of $5.4M. The latest reported quarter, Q4 2016, shows $0.

About the metric

What capital expenditures (CapEx) mean

Capital expenditures, commonly called CapEx, are cash investments in long-lived assets such as property, plants, equipment, infrastructure, and productive software. CapEx can support future growth or maintain existing operations, but it reduces current-period free cash flow.

Calculation and source

SEC-reported capital expenditures

TickerStat standardizes cash payments for property, plant, equipment, and other productive assets reported in company SEC filings. When a filer reports separate qualifying CapEx components instead of a total, those components are combined for the same fiscal period. Fiscal periods can differ from calendar years, so exact period-end dates are included.

Review SELLAS Life Sciences Group source filings ↗

Community posts

It’s quiet here.

No posts about SLS yet. Start the conversation.

Write the first post